Kazuto Tsuruda

1.5k total citations
46 papers, 1.1k citations indexed

About

Kazuto Tsuruda is a scholar working on Immunology, Molecular Biology and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, Kazuto Tsuruda has authored 46 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Immunology, 20 papers in Molecular Biology and 16 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in Kazuto Tsuruda's work include T-cell and Retrovirus Studies (24 papers), Vector-Borne Animal Diseases (16 papers) and Animal Disease Management and Epidemiology (10 papers). Kazuto Tsuruda is often cited by papers focused on T-cell and Retrovirus Studies (24 papers), Vector-Borne Animal Diseases (16 papers) and Animal Disease Management and Epidemiology (10 papers). Kazuto Tsuruda collaborates with scholars based in Japan, Netherlands and Belgium. Kazuto Tsuruda's co-authors include Yasuaki Yamada, Shimeru Kamihira, Hiroo Hasegawa, Kazuyuki Sugahara, Masao Tomonaga, Kunihiro Tsukasaki, Sunao Atogami, Takahiro Maeda, Katsunori Yanagihara and Hitomi Harasawa and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Kazuto Tsuruda

44 papers receiving 1.1k citations

Peers

Kazuto Tsuruda
Daniel Bertolette United States
M Tsudo United States
J Dittmer United States
Jeremy Kitson United Kingdom
Elisa S. Jansen Australia
Kazuto Tsuruda
Citations per year, relative to Kazuto Tsuruda Kazuto Tsuruda (= 1×) peers Shigeki Takemoto

Countries citing papers authored by Kazuto Tsuruda

Since Specialization
Citations

This map shows the geographic impact of Kazuto Tsuruda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuto Tsuruda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuto Tsuruda more than expected).

Fields of papers citing papers by Kazuto Tsuruda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuto Tsuruda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuto Tsuruda. The network helps show where Kazuto Tsuruda may publish in the future.

Co-authorship network of co-authors of Kazuto Tsuruda

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuto Tsuruda. A scholar is included among the top collaborators of Kazuto Tsuruda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuto Tsuruda. Kazuto Tsuruda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Winge-Main, A., et al.. (2024). Use of Immune Checkpoint Inhibitor (ICI) Therapy for Cutaneous Melanoma from 2014 to 2021 in Norway: Insights from Real-World Data. SHILAP Revista de lepidopterología. 2. 100170–100170.
2.
Itonaga, Hidehiro, Shinya Sato, Koji Ando, et al.. (2014). Expression of myeloperoxidase in acute myeloid leukemia blasts mirrors the distinct DNA methylation pattern involving the downregulation of DNA methyltransferase DNMT3B. Leukemia. 28(7). 1459–1466. 21 indexed citations
3.
Ishihara, Kaori, Kazuto Tsuruda, Yoshitomo Morinaga, et al.. (2013). RELEVANCE OF MOLECULAR TESTS FOR HTLV-1 INFECTION AS CONFIRMATORY TESTS AFTER THE FIRST SERO-SCREENING. Journal of Immunoassay and Immunochemistry. 35(1). 74–82. 4 indexed citations
4.
Ishihara, Kaori, Daisuke Sasaki, Kazuto Tsuruda, et al.. (2012). Impact of miR-155 and miR-126 as novel biomarkers on the assessment of disease progression and prognosis in adult T-cell leukemia. Cancer Epidemiology. 36(6). 560–565. 47 indexed citations
5.
Doi, Yuko, Daisuke Sasaki, Sayaka Mori, et al.. (2009). High-resolution melting analysis for a reliable and two-step scanning of mutations in the tyrosine kinase domain of the chimerical bcr-abl gene. International Journal of Hematology. 90(1). 37–43. 4 indexed citations
6.
Sugahara, Kazuyuki, Kazuto Tsuruda, Hiroo Hasegawa, et al.. (2008). Usefulness of long‐distance inverse polymerase chain reaction for molecular detection of 14q32 translocation in a clinical setting. Scandinavian Journal of Clinical and Laboratory Investigation. 68(7). 519–525. 1 indexed citations
7.
Kamihira, S, Kazuyuki Sugahara, Kazuto Tsuruda, et al.. (2005). Proviral status of HTLV-1 integrated into the host genomic DNA of adult T-cell leukemia cells. Clinical & Laboratory Haematology. 27(4). 235–241. 52 indexed citations
8.
Tawara, Masayuki, Yasuaki Yamada, Yumi Takasaki, et al.. (2005). Impact of p53 aberration on the progression of Adult T-cell Leukemia/Lymphoma. Cancer Letters. 234(2). 249–255. 42 indexed citations
9.
Mori, Yusuke, et al.. (2004). Automation of bone marrow aspirate examination using the XE‐2100 automated hematology analyzer. Cytometry Part B Clinical Cytometry. 58B(1). 25–31. 9 indexed citations
10.
Hasegawa, Hiroo, Yasuaki Yamada, Hitomi Harasawa, et al.. (2004). Restricted expression of tumor necrosis factor-related apoptosis-inducing ligand receptor 4 in human peripheral blood lymphocytes. Cellular Immunology. 231(1-2). 1–7. 13 indexed citations
11.
Tawara, Masayuki, Takahiro Maeda, Yasuaki Yamada, et al.. (2003). Aberrant processing of Fas transcripts in adult T-cell leukemia: a possible role in tumor cell survival. Cancer Letters. 193(2). 235–242. 5 indexed citations
12.
Hayashibara, Toshihisa, Yasuaki Yamada, Susumu Nakayama, et al.. (2002). Resveratrol Induces Downregulation in Survivin Expression and Apoptosis in HTLV-1-Infected Cell Lines: A Prospective Agent for Adult T Cell Leukemia Chemotherapy. Nutrition and Cancer. 44(2). 193–201. 48 indexed citations
13.
Yamada, Yasuaki, Naoki Mori, Toshihisa Hayashibara, et al.. (2002). Multiple γc‐receptor expression in adult T‐cell leukemia. European Journal Of Haematology. 68(6). 362–369. 13 indexed citations
14.
Li, Qian, Kazuto Tsuruda, Yasuaki Yamada, et al.. (2000). Qualitative and quantitative characterization of Fas (CD95) expression and its role in primary human acute leukemia cells. Leukemia Research. 24(5). 437–444. 10 indexed citations
15.
Yamada, Yasuaki, Kazuyuki Sugahara, Kazuto Tsuruda, et al.. (2000). Lactacystin activates FLICE (caspase 8) protease and induces apoptosis in Fas‐ resistant adult T‐cell leukemia cell lines. European Journal Of Haematology. 64(5). 315–322. 14 indexed citations
17.
Yamada, Yasuaki, Kazuyuki Sugahara, Kazuto Tsuruda, et al.. (1999). Fas-resistance in ATL cell lines not associated with HTLV-I or FAP-1 production. Cancer Letters. 147(1-2). 215–219. 13 indexed citations
18.
Sugahara, Kazuyuki, Kazuto Tsuruda, Yasuaki Yamada, et al.. (1999). Clonal Analysis of B-Cell Leukemias and Lymphomas using the Polymerase Chain Reaction for the Third Complementarity Determining Region of the IgH Gene: A Study of 75 Cases from Nagasaki Japan. Leukemia & lymphoma. 34(3-4). 387–393. 8 indexed citations
19.
Tsuruda, Kazuto, Yasuaki Yamada, Yoichi Hirakata, et al.. (1999). Qualitative and quantitative characterization of Fas (APO-1/CD95) on leukemic cells derived from patients with B-cell neoplasms. Leukemia Research. 23(2). 159–166. 18 indexed citations
20.
Sekine, Joji, et al.. (1994). Surgical management in the patient with congenital factor XII deficiency. Oral Surgery Oral Medicine Oral Pathology. 77(1). 13–15. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026